Priority Date: 30.07.12 (JP 20120168850)

COMPOUND AND PHARMACEUTICAL COMPOSITION FOR NEUROPSYCHOLOGICAL DISORDER OR MALIGNANT TUMOR

  • Application ID: EP13825401
  • Status: EXAMINATION IN PROGRESS

Applicants

Research organisation logo small
Research Organisation
Research organisation logo small
Research Organisation

Attorney

operating since 1920
1316.98
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 227 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 30.07.2012 - Priority Date (JP 20120168850)
  • 06.02.2014 - Publication A1 (WO2014021337)
  • 10.06.2015 - Publication A1 (EP2881397)